A focused update to AAD’s adult AD guidelines recommends tapinarof, roflumilast, lebrikizumab, and nemolizumab based on ...

Atopic dermatitis can flare up any day of the year, causing scaly patches of extremely dry, itchy, inflamed skin. But for many people living with atopic dermatitis, commonly known as eczema, the ...

The FDA has approved these four biologics to treat atopic dermatitis: dupilumab, lebrikizumab, nemolizumab, and tralokinumab. They are all types of biologics called monoclonal antibodies.

And atopic dermatitis is a specific form of and the most common type of eczema," dermatologist Naana Boakye, MD, says. It's a ...

New perspective proposes that skin microbiota disruption and bathing habits may play a primary role in atopic dermatitis, ...

Atopic dermatitis (AD) is a chronically relapsing eczematous disease, more common in infants and children than in adults and very rare after midlife. The diagnosis of AD is not always easy in ...

Winter season can trigger symptoms of atopic dermatitis by causing the skin to become dry and itchy in the cold weather. It can negatively affect one's quality of life.

Research at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe atopic dermatitis (eczema) in young children ...

Patients with atopic dermatitis (AD) may face a worse disease course if an impaired skin barrier triggers allergic contact dermatitis (ACD). 1-3 While the link between AD and photodermatoses has ...